Premium
Lyell Immunopharma Inc (LYEL)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Arch Venture Partners, L.P. | Institution | 3 247 162 | 13,92% | US$ 49,39M | 2026-03-31 |
| Innovative Cellular Therapeutics Holdings Limited | Institution | 2 857 500 | 12,25% | US$ 43,46M | 2026-06-29 |
| Explore Investments LLC | Institution | 1 529 054 | 6,55% | US$ 23,26M | 2026-03-31 |
| Gates Frontier, LLC | Institution | 1 529 054 | 6,55% | US$ 23,26M | 2026-03-31 |
| GSK Equity Investments, Limited | Institution | 1 512 659 | 6,48% | US$ 23,01M | 2026-03-31 |
| ARCH Venture Fund XIII, L.P. | Institution | 1 426 528 | 6,11% | US$ 21,70M | 2026-03-06 |
| Antonis Indianos | Initiés | 1 426 528 | 6,11% | US$ 21,70M | 2026-03-31 |
| Foresite Capital Management, LLC | Institution | 1 277 477 | 5,47% | US$ 19,43M | 2026-03-31 |
| Mwg Management Ltd. | Institution | 1 008 116 | 4,32% | US$ 15,33M | 2026-03-31 |
| ARCH Venture Partners IX LP | Institution | 910 317 | 3,90% | US$ 13,85M | 2026-03-06 |
| Arch Venture Fund IX Overage, L.P. | Institution | 910 317 | 3,90% | US$ 13,85M | 2026-03-06 |
| Foresite Capital Fund IV, L.P. | Institution | 800 339 | 3,43% | US$ 12,17M | 2025-09-30 |
| Apoletto Limited | Institution | 754 698 | 3,23% | US$ 11,48M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 718 155 | 3,08% | US$ 10,92M | 2026-03-31 |
| Decheng Capital LLC | Institution | 692 050 | 2,97% | US$ 10,53M | 2026-03-31 |
| Almitas Capital LLC | Institution | 577 807 | 2,48% | US$ 8,79M | 2026-03-31 |
| Foresite Capital Fund V, L.P. | Institution | 477 078 | 2,04% | US$ 7,26M | 2025-09-30 |
| Millennium Management LLC | Institution | 458 905 | 1,97% | US$ 6,98M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 381 462 | 1,63% | US$ 5,80M | 2026-03-31 |
| venBio LLC | Institution | 337 697 | 1,45% | US$ 5,14M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 330 998 | 1,42% | US$ 5,03M | 2026-03-31 |
| GV Management Company, LLC | Institution | 293 256 | 1,26% | US$ 4,46M | 2026-03-31 |
| BlackRock, Inc. | Institution | 191 820 | 0,82% | US$ 2,92M | 2026-03-31 |
| Dr. Richard Klausner | Initiés | 190 557 | 0,82% | US$ 2,90M | 2026-06-10 |
| Foresite Capital Opportunity Fund V, L.P. | Institution | 177 199 | 0,76% | US$ 2,70M | 2025-09-30 |
| Geode Capital Management, LLC | Institution | 166 980 | 0,72% | US$ 2,54M | 2026-03-31 |
| HongShan Capital Advisors Limited | Institution | 152 299 | 0,65% | US$ 2,32M | 2026-03-31 |
| Marshall Wace LLP | Institution | 148 516 | 0,64% | US$ 2,26M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 116 411 | 0,50% | US$ 1,77M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 114 491 | 0,49% | US$ 1,74M | 2026-03-31 |
| Velan Capital Partners LP | Institution | 102 000 | 0,44% | US$ 1,55M | 2026-03-31 |
| Invesco Capital Management LLC | Institution | 98 649 | 0,42% | US$ 1,50M | 2025-12-31 |
| MIC Capital Management UK LLP | Institution | 87 028 | 0,37% | US$ 1,32M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 86 925 | 0,37% | US$ 1,32M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 85 971 | 0,37% | US$ 1,31M | 2026-03-31 |
| Opaleye Management Inc. | Institution | 79 097 | 0,34% | US$ 1,20M | 2026-03-31 |
| Dr. Lynn Seely | Initiés | 73 878 | 0,32% | US$ 1,12M | 2026-05-11 |
| State Street Global Advisors, Inc. | Institution | 72 522 | 0,31% | US$ 1,10M | 2026-03-31 |
| Jane Street Group, LLC | Institution | 63 893 | 0,27% | US$ 971,81k | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 55 110 | 0,24% | US$ 838,22k | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 47 888 | 0,21% | US$ 728,38k | 2026-03-31 |
| RBF Capital LLC | Institution | 44 094 | 0,19% | US$ 670,67k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
